Diagnosis and Medical Management of Other Esophageal Motility Disorders

  • Mohammed Zakari
  • William Hirsch
  • Anthony LemboEmail author


The esophagus moves food and liquid from the oropharynx to the stomach. Efficient transport by the esophageal contents requires coordinated contractions that moves contents out of the esophagus and keeps gastric contents from excessively refluxing into the esophagus. Disruption of these esophageal peristalitc contractions limits movement of esophageal contents and may cause sensations of dysphagia and chest pain. Esophageal motility disorders are categorized according to their abnormal manometric patterns. Common causes of esophageal motility disorders excluding achalasia in this chapter.


Esophageal motility disorders Diffuse esophageal spasm (DES) Hypercontractile esophagus (HE) Absent contractility (AC) Esophagogastric junction outflow obstruction 


  1. 1.
    Pandolfino JE, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology. 2011;141(2):469–75.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Almansa C, et al. Esophageal spasm: demographic, clinical, radiographic, and manometric features in 108 patients. Dis Esophagus. 2012;25(3):214–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Herbella FA, et al. Primary versus secondary esophageal motility disorders: diagnosis and implications for treatment. J Laparoendosc Adv Surg Tech A. 2009;19(2):195–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Dogan I, et al. Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms. Am J Gastroenterol. 2007;102(1):137–45.CrossRefPubMedGoogle Scholar
  5. 5.
    Pehlivanov N, et al. Relationship between esophageal muscle thickness and intraluminal pressure in patients with esophageal spasm. Am J Physiol Gastrointest Liver Physiol. 2002;282(6):G1016–23.CrossRefPubMedGoogle Scholar
  6. 6.
    Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther. 2010;31(5):601–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Behar J, Biancani P. Pathogenesis of simultaneous esophageal contractions in patients with motility disorders. Gastroenterology. 1993;105(1):111–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Tutuian R, et al. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry. Am J Gastroenterol. 2006;101(3):464–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology. 1986;91(4):845–52.CrossRefPubMedGoogle Scholar
  10. 10.
    Richter JE, Bradley LA, Castell DO. Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med. 1989;110(1):66–78.CrossRefPubMedGoogle Scholar
  11. 11.
    Krishnan K, et al. Endoscopic ultrasound as an adjunctive evaluation in patients with esophageal motor disorders subtyped by high-resolution manometry. Neurogastroenterol Motil. 2014;26(8):1172–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Prabhakar A, et al. Relationship between diffuse esophageal spasm and lower esophageal sphincter dysfunction on barium studies and manometry in 14 patients. AJR Am J Roentgenol. 2004;183(2):409–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Nasrallah SM, et al. Primary esophageal motor disorders: clinical response to nifedipine. South Med J. 1985;78(3):312–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Thomas E, et al. Nifedipine therapy for diffuse esophageal spasm. South Med J. 1986;79(7):847–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Davies HA, et al. Trial of nifedipine for prevention of oesophageal spasm. Digestion. 1987;36(2):81–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Drenth JP, Bos LP, Engels LG. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther. 1990;4(4):411–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Swamy N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology. 1977;72(1):23–7.PubMedGoogle Scholar
  18. 18.
    Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol. 1995;30(11):1041–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Pimentel M, et al. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol. 2001;33(1):27–31.CrossRefPubMedGoogle Scholar
  20. 20.
    Fox M, et al. Sildenafil relieves symptoms and normalizes motility in patients with oesophageal spasm: a report of two cases. Neurogastroenterol Motil. 2007;19(10):798–803.CrossRefPubMedGoogle Scholar
  21. 21.
    Clouse RE, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology. 1987;92(4):1027–36.CrossRefPubMedGoogle Scholar
  22. 22.
    Handa M, et al. Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach. J Clin Gastroenterol. 1999;28(3):228–32.CrossRefPubMedGoogle Scholar
  23. 23.
    Cannon RO 3rd, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330(20):1411–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Pandak WM, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 2002;35(4):307–14.CrossRefPubMedGoogle Scholar
  25. 25.
    Fass R, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115(1):42–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Achem SR, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997;42(10):2138–45.CrossRefPubMedGoogle Scholar
  27. 27.
    Bautista J, et al. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain–a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2004;19(10):1123–30.CrossRefPubMedGoogle Scholar
  28. 28.
    Vanuytsel T, et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11(9):1115–1121.e2.CrossRefPubMedGoogle Scholar
  29. 29.
    Patel DA, Vaezi MF. A spiraling case of persistent dysphagia. Diffuse Esophageal Spasm. Gastroenterology. 2015;149(2):298–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Miller LS, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol. 2002;97(7):1640–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    van Hoeij FB, et al. Complications of botulinum toxin injections for treatment of esophageal motility disordersdagger. Dis Esophagus. 2017;30(3):1–5. Scholar
  32. 32.
    Irving JD, et al. Management of diffuse esophageal spasm with balloon dilatation. Gastrointest Radiol. 1992;17(3):189–92.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Minami H, et al. Peroral endoscopic myotomy (POEM) for diffuse esophageal spasm. Endoscopy. 2014;46(Suppl 1 UCTN):E79–81.PubMedGoogle Scholar
  34. 34.
    Louis H, et al. Distal esophageal spasm treated by peroral endoscopic myotomy. Am J Gastroenterol. 2012;107(12):1926–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Shiwaku H, et al. Successful treatment of diffuse esophageal spasm by peroral endoscopic myotomy. Gastrointest Endosc. 2013;77(1):149–50.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Spencer HL, Smith L, Riley SA. A questionnaire study to assess long-term outcome in patients with abnormal esophageal manometry. Dysphagia. 2006;21(3):149–55.CrossRefPubMedGoogle Scholar
  37. 37.
    Khatami SS, et al. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci. 2005;50(9):1605–10.CrossRefPubMedGoogle Scholar
  38. 38.
    Fontes LH, et al. Progression of diffuse esophageal spasm to achalasia: incidence and predictive factors. Dis Esophagus. 2013;26(5):470–4.CrossRefPubMedGoogle Scholar
  39. 39.
    Tedesco P, et al. Cause and treatment of epiphrenic diverticula. Am J Surg. 2005;190(6):891–4.CrossRefPubMedGoogle Scholar
  40. 40.
    Roman S, Kahrilas PJ. Distal esophageal spasm. Curr Opin Gastroenterol. 2015;31(4):328–33.CrossRefPubMedGoogle Scholar
  41. 41.
    Pandolfino JE, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol. 2008;103(1):27–37.CrossRefPubMedGoogle Scholar
  42. 42.
    Kushnir VM, Prakash Gyawali C. High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain. Neurogastroenterol Motil. 2011;23(12):1066–72.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Roman S, et al. Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT). Am J Gastroenterol. 2012;107(1):37–45.CrossRefPubMedGoogle Scholar
  44. 44.
    Brito EM, et al. Effect of different swallow time intervals on the nutcracker esophagus. Am J Gastroenterol. 2003;98(1):40–5.CrossRefPubMedGoogle Scholar
  45. 45.
    Jung HY, et al. Asynchrony between the circular and the longitudinal muscle contraction in patients with nutcracker esophagus. Gastroenterology. 2005;128(5):1179–86.CrossRefGoogle Scholar
  46. 46.
    Sugarbaker DJ, Rattan S, Goyal RK. Mechanical and electrical activity of esophageal smooth muscle during peristalsis. Am J Phys. 1984;246(2 Pt 1):G145–50.Google Scholar
  47. 47.
    Sugarbaker DJ, Rattan S, Goyal RK. Swallowing induces sequential activation of esophageal longitudinal smooth muscle. Am J Phys. 1984;247(5 Pt 1):G515–9.Google Scholar
  48. 48.
    Burton PR, et al. The effect of laparoscopic adjustable gastric bands on esophageal motility and the gastroesophageal junction: analysis using high-resolution video manometry. Obes Surg. 2009;19(7):905–14.CrossRefPubMedGoogle Scholar
  49. 49.
    Mittal RK, et al. Modulation of feline esophageal contractions by bolus volume and outflow obstruction. Am J Phys. 1990;258(2 Pt 1):G208–15.Google Scholar
  50. 50.
    Mallet AL, et al. Prevalence and characteristics of acid gastro-oesophageal reflux disease in Jackhammer oesophagus. Dig Liver Dis. 2016;48(10):1136–41.CrossRefPubMedGoogle Scholar
  51. 51.
    Achem SR, et al. Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol. 1993;88(2):187–92.PubMedGoogle Scholar
  52. 52.
    Melchior C, et al. Recovery of a “Jackhammer esophagus” after the treatment of an eosinophilic esophagitis. Am J Gastroenterol. 2012;107(6):952–4; author reply 954–5.CrossRefPubMedGoogle Scholar
  53. 53.
    Song CW, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol. 2001;96(8):2312–6.CrossRefPubMedGoogle Scholar
  54. 54.
    Herregods TV, et al. Jackhammer esophagus: observations on a European cohort. Neurogastroenterol Motil. 2016;Google Scholar
  55. 55.
    Ko WJ, et al. Jackhammer esophagus treated by a peroral endoscopic myotomy. Korean J Gastroenterol. 2014;64(6):370–4.CrossRefPubMedGoogle Scholar
  56. 56.
    Pandolfino JE, Kahrilas PJ, A. American Gastroenterological. AGA technical review on the clinical use of esophageal manometry. Gastroenterology. 2005;128(1):209–24.CrossRefPubMedGoogle Scholar
  57. 57.
    Roman S, Kahrilas PJ. Management of spastic disorders of the esophagus. Gastroenterol Clin N Am. 2013;42(1):27–43.CrossRefGoogle Scholar
  58. 58.
    Marjoux S, et al. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases? Dis Esophagus. 2015;28(8):735–41.CrossRefPubMedGoogle Scholar
  59. 59.
    Kandulski A, et al. Jackhammer esophagus: high-resolution manometry and therapeutic approach using peroral endoscopic myotomy (POEM). Dis Esophagus. 2016;29(6):695–6.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Khashab MA, et al. Jet injection of dyed saline facilitates efficient peroral endoscopic myotomy. Endoscopy. 2014;46(4):298–301.PubMedGoogle Scholar
  61. 61.
    Abdallah J, Fass R. Progression of Jackhammer esophagus to type II achalasia. J Neurogastroenterol Motil. 2016;22(1):153–6.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Huang L, Pimentel M, Rezaie A. Do Jackhammer contractions lead to achalasia? A longitudinal study. Neurogastroenterol Motil. 2016;29(3)
  63. 63.
    Calderaro DC, de Carvalho MA, Moretzsohn LD. Esophageal manometry in 28 systemic sclerosis Brazilian patients: findings and correlations. Dis Esophagus. 2009;22(8):700–4.CrossRefPubMedGoogle Scholar
  64. 64.
    Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006;40(9):769–75.CrossRefGoogle Scholar
  65. 65.
    Ntoumazios SK, et al. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 2006;36(3):173–81.CrossRefPubMedGoogle Scholar
  66. 66.
    Szamosi S, Szekanecz Z, Szucs G. Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int. 2006;26(12):1120–4.CrossRefPubMedGoogle Scholar
  67. 67.
    Marie I, et al. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24(11–12):1593–601.CrossRefPubMedGoogle Scholar
  68. 68.
    Treacy WL, et al. Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med. 1963;59:351–6.CrossRefPubMedGoogle Scholar
  69. 69.
    Vischio J, et al. Progression of esophageal dysmotility in systemic sclerosis. J Rheumatol. 2012;39(5):986–91.CrossRefPubMedGoogle Scholar
  70. 70.
    Airo P, et al. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol. 2005;24(4):370–6.CrossRefPubMedGoogle Scholar
  71. 71.
    Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994;37(9):1265–82.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Kaye SA, et al. Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud’s phenomenon or chronic vasculopathy? QJM. 1994;87(8):495–500.PubMedGoogle Scholar
  73. 73.
    Pitrez EH, et al. Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy. Br J Radiol. 2006;79(945):719–24.CrossRefPubMedGoogle Scholar
  74. 74.
    Manetti M, et al. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum. 2007;56(10):3442–7.CrossRefPubMedGoogle Scholar
  75. 75.
    Kahari VM. Activation of dermal connective tissue in scleroderma. Ann Med. 1993;25(6):511–8.PubMedGoogle Scholar
  76. 76.
    Santos-Navarro RR, et al. Clinical, endoscopic and manometric findings in the gastroesophageal tract of patients with systemic sclerosis. Rev Med Inst Mex Seguro Soc. 2008;46(5):503–10.PubMedGoogle Scholar
  77. 77.
    Abu-Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum. 1994;24(1):29–39.CrossRefPubMedGoogle Scholar
  78. 78.
    Hendel L, et al. Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther. 1992;6(5):565–77.CrossRefPubMedGoogle Scholar
  79. 79.
    Scherer JR, et al. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg. 2009;13(12):2219–25.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Bredenoord AJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Ciriza-de-Los-Rios C, Canga-Rodriguez-Valcarcel F. High-resolution manometry and impedance-pH/manometry: novel techniques for the advancement of knowledge on esophageal function and their clinical role. Rev Esp Enferm Dig. 2009;101(12):861–9.CrossRefPubMedGoogle Scholar
  82. 82.
    Kahrilas PJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.CrossRefGoogle Scholar
  83. 83.
    van Hoeij FB, Smout AJ, Bredenoord AJ. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2015;27(9):1310–6.CrossRefPubMedGoogle Scholar
  84. 84.
    Poochong Timratana MJL, Nieman DR, Han MS, Christian G, Peyre CEJ, Watson TJ, Peters JH. The clinical spectrum of esophagogastric junction outflow obstruction identified via high resolution manometry. Gastroenterolgoy. 2013;144(5, Suppl 1):S-1099.CrossRefGoogle Scholar
  85. 85.
    Okeke FC, Raja S, Lynch KL, Dhalla S, Nandwani M, Stein EM, Chander Roland B, et al. What is the clinical significance of EGJ outflow obstruction? Evaluation of 60 patients at a tertiary referral center. Gastroenterology. 2014;146:S-101.CrossRefGoogle Scholar
  86. 86.
    Clayton SB, Patel R, Richter JE. Functional and anatomic Esophagogastic junction outflow obstruction: manometry, timed barium Esophagram findings, and treatment outcomes. Clin Gastroenterol Hepatol. 2016;14(6):907–11.CrossRefPubMedGoogle Scholar
  87. 87.
    Perez-Fernandez MT, et al. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28(1):116–26.CrossRefPubMedGoogle Scholar
  88. 88.
    DeLay K, Austin GL, Menard-Katcher P. Anatomic abnormalities are common potential explanations of manometric esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2016;28(8):1166–71.CrossRefPubMedGoogle Scholar
  89. 89.
    Kaul BK, et al. The cause of dysphagia in uncomplicated sliding hiatal hernia and its relief by hiatal herniorrhaphy. A roentgenographic, manometric, and clinical study. Ann Surg. 1990;211(4):406–10.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Penagini R, Bianchi PA. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterology. 1997;113(2):409–14.CrossRefPubMedGoogle Scholar
  91. 91.
    Penagini R, Picone A, Bianchi PA. Effect of morphine and naloxone on motor response of the human esophagus to swallowing and distension. Am J Phys. 1996;271(4 Pt 1):G675–80.Google Scholar
  92. 92.
    Ratuapli SK, et al. Opioid-Induced Esophageal Dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110(7):979–84.CrossRefPubMedGoogle Scholar
  93. 93.
    Weijenborg PW, et al. Normal values for solid-state esophageal high-resolution manometry in a European population; an overview of all current metrics. Neurogastroenterol Motil. 2014;26(5):654–9.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Mittal RK, et al. The effects of psychological stress on the esophagogastric junction pressure and swallow-induced relaxation. Gastroenterology. 1994;106(6):1477–84.CrossRefPubMedGoogle Scholar
  95. 95.
    Galey KM, et al. Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features. J Am Coll Surg. 2011;213(1):155–61. discussion 162-3CrossRefPubMedGoogle Scholar
  96. 96.
    Singh S, et al. Nonobstructive dysphagia in gastroesophageal reflux disease: a study with combined ambulatory pH and motility monitoring. Am J Gastroenterol. 1992;87(5):562–7.PubMedGoogle Scholar
  97. 97.
    Spieker MR. Evaluating dysphagia. Am Fam Physician. 2000;61(12):3639–48.PubMedGoogle Scholar
  98. 98.
    Roman S, Kahrilas PJ. Challenges in the swallowing mechanism: nonobstructive dysphagia in the era of high-resolution manometry and impedance. Gastroenterol Clin N Am. 2011;40(4):823–35. ix-xCrossRefGoogle Scholar
  99. 99.
    Ghosh SK, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol. 2007;293(4):G878–85.CrossRefPubMedGoogle Scholar
  100. 100.
    Rohof WO, et al. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328–35.CrossRefGoogle Scholar
  101. 101.
    Pandolfino JE, et al. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.CrossRefPubMedPubMedCentralGoogle Scholar
  102. 102.
    Smeets FG, et al. Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome. Neurogastroenterol Motil. 2015;27(10):1495–503.CrossRefPubMedGoogle Scholar
  103. 103.
    Carlson DA, et al. Evaluation of esophageal motility utilizing the functional lumen imaging probe. Am J Gastroenterol. 2016;111:1726.CrossRefPubMedPubMedCentralGoogle Scholar
  104. 104.
    Porter RF, Gyawali CP. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2011;23(2):139–44, e27–8.CrossRefPubMedGoogle Scholar
  105. 105.
    Shin IS, Min YW, Rhee PL. Esophagogastric junction outflow obstruction transformed to type II achalasia. J Neurogastroenterol Motil. 2016;22(2):344–5.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© SAGES 2019

Authors and Affiliations

  • Mohammed Zakari
    • 1
  • William Hirsch
    • 1
  • Anthony Lembo
    • 1
    Email author
  1. 1.Division of Gastroenterology, Department of MedicineBeth Israel Deaconess Medical CenterBostonUSA

Personalised recommendations